Cytek Biosciences Statistics
Total Valuation
CTKB has a market cap or net worth of $513.03 million. The enterprise value is $251.54 million.
Important Dates
The next estimated earnings date is Wednesday, May 7, 2025, after market close.
Earnings Date | May 7, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
CTKB has 128.10 million shares outstanding. The number of shares has decreased by -3.45% in one year.
Current Share Class | 128.10M |
Shares Outstanding | 128.10M |
Shares Change (YoY) | -3.45% |
Shares Change (QoQ) | -2.79% |
Owned by Insiders (%) | 9.03% |
Owned by Institutions (%) | 55.52% |
Float | 109.80M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | 36.36 |
PS Ratio | 2.61 |
Forward PS | 2.36 |
PB Ratio | 1.31 |
P/TBV Ratio | 1.43 |
P/FCF Ratio | 23.45 |
P/OCF Ratio | 20.19 |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | 1.25 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | 11.51 |
Financial Position
The company has a current ratio of 5.86, with a Debt / Equity ratio of 0.04.
Current Ratio | 5.86 |
Quick Ratio | 5.00 |
Debt / Equity | 0.04 |
Debt / EBITDA | n/a |
Debt / FCF | 0.78 |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -1.53% and return on invested capital (ROIC) is -3.53%.
Return on Equity (ROE) | -1.53% |
Return on Assets (ROA) | -2.91% |
Return on Invested Capital (ROIC) | -3.53% |
Return on Capital Employed (ROCE) | -5.35% |
Revenue Per Employee | $309,341 |
Profits Per Employee | -$9,290 |
Employee Count | 648 |
Asset Turnover | 0.40 |
Inventory Turnover | 1.70 |
Taxes
In the past 12 months, CTKB has paid $320,000 in taxes.
Income Tax | 320,000 |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -39.67% in the last 52 weeks. The beta is 1.42, so CTKB's price volatility has been higher than the market average.
Beta (5Y) | 1.42 |
52-Week Price Change | -39.67% |
50-Day Moving Average | 4.92 |
200-Day Moving Average | 5.63 |
Relative Strength Index (RSI) | 32.04 |
Average Volume (20 Days) | 958,660 |
Short Selling Information
The latest short interest is 3.81 million, so 2.97% of the outstanding shares have been sold short.
Short Interest | 3.81M |
Short Previous Month | 3.45M |
Short % of Shares Out | 2.97% |
Short % of Float | 3.47% |
Short Ratio (days to cover) | 5.13 |
Income Statement
In the last 12 months, CTKB had revenue of $200.45 million and -$6.02 million in losses. Loss per share was -$0.05.
Revenue | 200.45M |
Gross Profit | 111.11M |
Operating Income | -23.12M |
Pretax Income | -16.25M |
Net Income | -6.02M |
EBITDA | -15.91M |
EBIT | -23.12M |
Loss Per Share | -$0.05 |
Full Income Statement Balance Sheet
The company has $277.86 million in cash and $17.02 million in debt, giving a net cash position of $260.85 million or $2.04 per share.
Cash & Cash Equivalents | 277.86M |
Total Debt | 17.02M |
Net Cash | 260.85M |
Net Cash Per Share | $2.04 |
Equity (Book Value) | 395.74M |
Book Value Per Share | 3.06 |
Working Capital | 328.78M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was $25.38 million and capital expenditures -$3.53 million, giving a free cash flow of $21.85 million.
Operating Cash Flow | 25.38M |
Capital Expenditures | -3.53M |
Free Cash Flow | 21.85M |
FCF Per Share | $0.17 |
Full Cash Flow Statement Margins
Gross margin is 55.43%, with operating and profit margins of -11.54% and -3.00%.
Gross Margin | 55.43% |
Operating Margin | -11.54% |
Pretax Margin | -2.84% |
Profit Margin | -3.00% |
EBITDA Margin | -7.94% |
EBIT Margin | -11.54% |
FCF Margin | 10.90% |
Dividends & Yields
CTKB does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | 3.45% |
Shareholder Yield | 3.45% |
Earnings Yield | -1.17% |
FCF Yield | 4.27% |
Analyst Forecast
The average price target for CTKB is $7.00, which is 74.78% higher than the current price. The consensus rating is "Buy".
Price Target | $7.00 |
Price Target Difference | 74.78% |
Analyst Consensus | Buy |
Analyst Count | 2 |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
CTKB has an Altman Z-Score of 5.79 and a Piotroski F-Score of 4.
Altman Z-Score | 5.79 |
Piotroski F-Score | 4 |